Incidence of intestinal obstruction following intraperitoneal chemotherapy for ovarian tubal and peritoneal malignancies

Gynecologic Oncology

Volumn 113, Issue 2, 2009, Pages 228-232

  Kehoe, Siobhan M ^a   Williams, Ned L ^a   Yakubu, Rasheed ^a   Levine, Douglas A ^a   Chi, Dennis S ^a   Sabbatini, Paul J ^a   Aghajanian, Carol A ^a   Barakat, Richard R ^a   Abu Rustum, Nadeem R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Intestinal obstruction; Intraperitoneal chemotherapy; Ovarian tubal malignancies; Peritoneal malignancies

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYTARABINE; ETOPOSIDE; FLOXURIDINE; FLUOROURACIL; GEMCITABINE; MITOXANTRONE; PACLITAXEL;

ADULT; AGED; ARTICLE; CONSERVATIVE TREATMENT; FEMALE; FOLLOW UP; GASTROSTOMY; HUMAN; INCIDENCE; INTESTINE OBSTRUCTION; INTESTINE SURGERY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; OVARY CANCER; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PERITONEUM CANCER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UTERINE TUBE CARCINOMA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CATHETERS, INDWELLING; CISPLATIN; FALLOPIAN TUBE NEOPLASMS; FEMALE; HUMANS; INFUSIONS, PARENTERAL; INTESTINAL OBSTRUCTION; MIDDLE AGED; MITOXANTRONE; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 63749092195     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.01.016     Document Type: Article

References (12)

1. Alberts D.S., Liu P.Y., Hannigan E.V., et al. Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. N. Engl. J. Med. 335 (1996) 1950-1955
2. Markman M., Bundy B.N., Alberts D.S., et al. Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, and Eastern Cooperative Oncology Group. J. Clin. Oncol. 19 (2001) 1001-1007
3. Armstrong D.K., Bundy B., Wenzel L., et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N. Engl. J. Med. 354 (2006) 34-43
4. Marth C., Walker J.L., Barakat R.R., et al. Results of the 2006 Innsbruck International Consensus Conference on Intraperitoneal Chemotherapy in Patients with Ovarian Cancer. Cancer 109 (2007) 645-649
5. Landrum L.M., Gold M.A., Moore K.N., et al. Intraperitoneal chemotherapy for patients with advanced epithelial ovarian cancer: a review of complications and completion rates. Gyn. Onc. 108 (2008) 342-347
6. Markman M., and Walker J. Intraperitoneal chemotherapy of ovarian cancer: a review, with a focus on practical aspects of treatment. J. Clin. Oncol. 24 (2006) 988-993
7. Black D., Levine D.A., Nicoll L., et al. Low risk of complications associated with the fenestrated peritoneal catheter used for intraperitoneal chemotherapy in ovarian cancer. Gynecol. Oncol. 109 (2008) 39-42
8. Sakuragi N., Nakajima A., Nomura E., et al. Complications relating to intraperitoneal administration of cisplatin or carboplatin for ovarian cancer. Gynecol. Oncol. 79 (2000) 420-423
9. Barakat R.R., Sabbatini P., Bhaskaran D., et al. Intraperitoneal Chemotherapy of ovarian carcinoma: results of long-term follow-up. J. Clin. Oncol. 20 (2006) 694-698
10. Makhija S., Leitao M., Sabbatini P., et al. Complications associated with intraperitoneal chemotherapy catheters. Gyn. Onc. 81 (2001) 77-81
11. Bryan D.N., Radbod R., and Berek J.S. An analysis of surgical versus chemotherapeutic intervention for the management of intestinal obstruction in advanced ovarian cancer. Int. J. Gynecol. Cancer 16 (2006) 125-134
12. Vergote I.B., Winderen M., De Vos L.N., et al. Intraperitoneal radioactive phosphorus therapy in ovarian carcinoma. Analysis of 313 patients treated primarily or at second look laparotomy. Cancer 71 (1993) 2250-2260